Review article · 2024 · Open access

Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies

Pritee Chunarkar Patil, Mohammed Kaleem, Richa Mishra, Subhasree Ray, Aftab Ahmad, Devvret Verma, Sagar S. Bhayye, Rajni Dubey, Himanshu Narayan Singh, Sanjay Kumar

Biomedicines, 12(1), 201 · Published 16 January 2024 · DOI 10.3390/biomedicines12010201

Free PDFView at the publisherCite this paper

In brief

“Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies” is a 2024 review article by Pritee Chunarkar Patil and 9 co-authors, published in Biomedicines. OpenAlex counts 455 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Biomedicines.

Citations
455
Most cited in
2025 (200)
Field-weighted impact
11.70
References
229
Authors
10

Abstract

Globally, malignancies cause one out of six mortalities, which is a serious health problem. Cancer therapy has always been challenging, apart from major advances in immunotherapies, stem cell transplantation, targeted therapies, hormonal therapies, precision medicine, and palliative care, and traditional therapies such as surgery, radiation therapy, and chemotherapy. Natural products are integral to the development of innovative anticancer drugs in cancer research, offering the scientific community the possibility of exploring novel natural compounds against cancers. The role of natural products like Vincristine and Vinblastine has been thoroughly implicated in the management of leukemia and Hodgkin's disease. The computational method is the initial key approach in drug discovery, among various approaches. This review investigates the synergy between natural products and computational techniques, and highlights their significance in the drug discovery process. The transition from computational to experimental validation has been highlighted through in vitro and in vivo studies, with examples such as betulinic acid and withaferin A. The path toward therapeutic applications have been demonstrated through clinical studies of compounds such as silvestrol and artemisinin, from preclinical investigations to clinical trials. This article also addresses the challenges and limitations in the development of natural products as potential anti-cancer drugs. Moreover, the integration of deep learning and artificial intelligence with traditional computational drug discovery methods may be useful for enhancing the anticancer potential of natural products.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Patil, P. C., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S. S., Dubey, R., Singh, H. N., & Kumar, S. (2024). Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies. Biomedicines, 12(1), 201. https://doi.org/10.3390/biomedicines12010201

MLA 9

Patil, Pritee Chunarkar, et al. “Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies.” Biomedicines, vol. 12, no. 1, 2024, p. 201. https://doi.org/10.3390/biomedicines12010201.

Chicago

Patil, Pritee Chunarkar, Mohammed Kaleem, Richa Mishra, Subhasree Ray, Aftab Ahmad, Devvret Verma, Sagar S. Bhayye, Rajni Dubey, Himanshu Narayan Singh, and Sanjay Kumar. 2024. “Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies.” Biomedicines 12 (1): 201. https://doi.org/10.3390/biomedicines12010201.

Harvard

Patil, P. C. et al. (2024) ‘Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies’, Biomedicines, 12(1), p. 201. doi:10.3390/biomedicines12010201.

IEEE

P. C. Patil et al., “Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies,” Biomedicines, vol. 12, no. 1, p. 201, 2024, doi: 10.3390/biomedicines12010201.

BibTeX

@article{patil2024anticancer,
  title     = {{Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies}},
  author    = {Patil, Pritee Chunarkar and Kaleem, Mohammed and Mishra, Richa and Ray, Subhasree and Ahmad, Aftab and Verma, Devvret and Bhayye, Sagar S. and Dubey, Rajni and Singh, Himanshu Narayan and Kumar, Sanjay},
  journal   = {Biomedicines},
  year      = {2024},
  volume    = {12},
  number    = {1},
  pages     = {201},
  doi       = {10.3390/biomedicines12010201},
  url       = {https://doi.org/10.3390/biomedicines12010201}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201811
202011
20245656
2025200200
2026197197

Its field-weighted citation impact is 11.70: it has been cited 11.70 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • anticancer drug discovery
  • natural products
  • computational drug discovery
  • betulinic acid
  • withaferin A
  • silvestrol
  • artemisinin
  • vincristine

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Patil, P. C., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S. S., Dubey, R., Singh, H. N., & Kumar, S. (2024). Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies. Biomedicines, 12(1), 201. https://doi.org/10.3390/biomedicines12010201

How many times has this paper been cited?

455 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Biomedicines.

Who wrote this paper?

Pritee Chunarkar Patil, Mohammed Kaleem, Richa Mishra, Subhasree Ray, Aftab Ahmad, Devvret Verma, Sagar S. Bhayye, Rajni Dubey, Himanshu Narayan Singh, Sanjay Kumar.

What is the DOI of this paper?

10.3390/biomedicines12010201. The permanent link is https://doi.org/10.3390/biomedicines12010201.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.